Finally, miR-27a*, as a potential onco-miR, can trigger tumor cell EMT initiation and promote cancer progression via directly targeting Fbxo45 to disrupt the SPFFbxo45 complex, thereby maintaining the protein stabilities of EMT-TFs, along with characteristic phenotypes of malignant cells (Fig 7A). The gene discussed is FBXO45; the disease is neoplasm.